GLP-1/胰高血糖素激动剂

4 · 20 / page

Ask MedXY AI

Latest news

Tag

Diabetes & EndocrinologyGLP-1/胰高血糖素激动剂metabolic complications

Next-Generation Pharmacotherapies in Obesity: Transforming Care with Precision and Multisystem Benefits

By MedXY|Jul 14, 2026

Emerging obesity pharmacotherapies targeting entero-pancreatic hormones deliver substantial weight loss and improve multiple obesity-related complications, heralding a treat-to-target paradigm in obesity management with personalized, compli

Efficacy and Safety of Cagrilintide-Semaglutide Combination vs Semaglutide Alone for Weight Management in East Asian Adults with Overweight/Obesity: REDEFINE 5 Trial

Diabetes & Endocrinologyamylin analogue

GLP-1/胰高血糖素激动剂

Latest news

Next-Generation Pharmacotherapies in Obesity: Transforming Care with Precision and Multisystem Benefits

Efficacy and Safety of Cagrilintide-Semaglutide Combination vs Semaglutide Alone for Weight Management in East Asian Adults with Overweight/Obesity: REDEFINE 5 Trial

Holding GLP-1/GIP Agonists Before Upper Endoscopy Reduces Residual Gastric Volume Risk: Insights from the OCULUS Randomized Trial

Liraglutide and Alzheimer’s Disease: Can GLP-1 Agonists Bridge the Metabolic-Cognitive Gap?